Future Lipidology

LCAT deficiency: molecular genetics, lipid/lipoprotein phenotype and atherosclerosis
pp. 241-245(5)
Authors: Calabresi, Laura; Moleri, Elsa; Franceschini, Guido

NPC1L1: from drug target to physiological sterol transporter
pp. 247-249(3)
Authors: L Pollex, Rebecca; A Hegele, Robert

Big competition on a tiny scale
pp. 251-253(3)

Ezetimibe: one step beyond in the battle against atherosclerosis
pp. 255-266(12)
Authors: Ibanez, Borja; Badimon, Juan

Use of orlistat in obese, dyslipidemic patients
pp. 267-273(7)
Authors: H Nelson, Robert; M Miles, John

When it comes to the FIELD study, what is...is
pp. 275-281(7)
Author: McKenney, James M

The health consequences in African-Americans of each component of the metabolic syndrome
pp. 283-289(7)
Author: Sumner, Anne E

Transport of fatty acids into adipocytes
pp. 291-298(8)
Authors: Wiczer, Brian M; Lobo, Sandra; Bernlohr, David A

LDL-apheresis therapy: current therapeutic practice and potential future use
pp. 299-308(10)
Author: Moriarty, Patrick M

Noninvasive preclinical assessment of CAD
pp. 309-320(12)
Authors: Gul, Khawar M; Budoff, Matthew J

Oxidized lipoprotein autoimmunity: an emerging drug target in cardiovascular disease
pp. 321-330(10)
Authors: Nilsson, Jan; Fredrikson, Gunilla Nordin; Chyu, Kuang-Yuh; Shah, Prediman K; Björkbacka, Harry

Future directions in reducing hepatic lipotoxicity
pp. 331-341(11)
Authors: Torres, Nimbe; Torre-Villalvazo, Ivan; R Tovar, Armando

HDL and endothelial function: from molecular mechanisms to clinical observations
pp. 343-355(13)
Authors: Norata, Giuseppe Danilo; Raselli, Sara; Catapano, Alberico Luigi

Tracking the dietary cholesterol molecule
pp. 357-368(12)
Authors: Kidambi, Srividya; Solca, Curzio; Patel, Shailendra